Utility of a Urine Screening Tool for Vitamin D Deficiency in Infants and Toddlers

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-03-31

Study Completion Date

2011-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background:

Vitamin D plays a key role in calcium absorption in the gut and in skeletal development. Vitamin D deficiency is common, affecting an estimated one billion people worldwide, including developed countries. Vitamin D deficiency causes rickets, the most common non-communicable disease of childhood. Rickets causes poor growth and skeletal deformities and, at its most severe, seizures and death. Recent data suggest that children with rickets have an increased risk for developing diabetes mellitus.

Screening for vitamin D deficiency is not commonly done. It is generally diagnosed only after symptoms of rickets have developed. Prevention and treatment is simple and inexpensive. Hence, early detection of vitamin D deficiency through screening would be beneficial. Studies are urgently needed to validate such screening tests.

Calcium balance is tightly regulated in the body and calcium loss in the urine (measured by the urine calcium-to-creatinine ratio) is a sensitive indicator of reduced calcium absorption, such as in vitamin D deficiency.

Objective and Hypotheses. The objective of this study is to evaluate the urine calcium-to-creatinine ratio as a noninvasive and inexpensive screening test for vitamin D deficiency. Our hypotheses are 1) that the urine calcium-to-creatinine ratio correlates with blood vitamin D levels in infants and toddlers at risk for vitamin D deficiency and 2) that this test can be used to screen for vitamin D deficiency.

Potential Impact. A validated screening tool would allow for the detection of vitamin D deficiency before the development of rickets, decreasing the morbidity and mortality of this common disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study to Assess the Use of a Simple Lab Test to Screen for Rickets in Children

NCT00502866

Rickets

COMPLETED

Pilot Pharmacokinetic Study of Daily Versus Monthly High-Dose Cholecalciferol Supplementation

NCT01079923

Healthy Volunteers

COMPLETED NA

Effects of Vitamin D Dose and Genotype of the Binding Protein in Infants and Children

NCT01050387

Vitamin D Deficiency

COMPLETED NA

Efficacy of Usual Vitamin D Supplementation and Its Impact on Children and Adolescents Calciuria.

NCT02238418

Chronic Kidney Disease Renal Transplantation Nephrotic Syndrome

COMPLETED PHASE4

Vitamin D Deficiency of Couples and Infertility

NCT03305510

Vitamin D Deficiency Infertility Couples +1 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background:

Insufficient circulating levels of vitamin D is a common problem in both developed and developing countries; it is estimated that over one billion people have vitamin D deficiency at this time. In children, vitamin D deficiency leads to nutritional rickets, which is considered the most common non-communicable disease of children worldwide. Rickets causes significant short term morbidity and mortality through hypocalcemic tetany and seizures, as well as long term morbidity from growth delay and skeletal deformities. Recent data also suggest that children who have had nutritional rickets are three times more likely to develop type 1 diabetes.

There is wide agreement that screening for vitamin D deficiency would be highly beneficial. However, there is debate on how best to do this. Most screening efforts have included serum levels of 25-hydroxy-vitamin D and parathyroid hormone (PTH). However, these assays are complex and are neither available nor affordable for many of the most vulnerable populations.

Calcium excretion in the kidney is a tightly regulated process involving metabolites of vitamin D and PTH. Renal calcium excretion, in the absence of primary renal or parathyroid gland disease, is a sensitive indicator of total body calcium balance. We have shown that renal calcium excretion correlates with blood levels of 25-hydroxy-vitamin D levels in older children and urine calcium-to-creatinine ratios have been shown to distinguish children with active rickets from healthy controls in one Nigerian study. This biomarker is noninvasive and the assays are straight forward and inexpensive. We believe that the urine calcium-to-creatinine ratio has excellent potential as a screening tool for vitamin D deficiency.

Objective and Hypotheses. The objective of this study is to evaluate the urine calcium-to-creatinine ratio as a biomarker of vitamin D deficiency. Our hypotheses are 1) that urine calcium-to-creatinine ratio correlates with serum 25-hydroxy vitamin D level in infants and toddlers at risk for vitamin D deficiency and 2) that the urine calcium-to-creatinine ratio can be used to screen children for vitamin D deficiency. These hypotheses will be tested through two specific aims. Specific Aim 1 is to determine the correlation between the urine calcium-to-creatinine ratio with 25-hydroxy vitamin D levels and with biomarkers of rickets in infants and toddlers at increased risk for vitamin D deficiency. Specific Aim 2 is to determine the sensitivity, specificity, and positive and negative predictive values of one random urine calcium-to-creatinine ratio in relation to biochemical evidence of vitamin D deficiency.

Design. This will be an observational study of infants and toddlers at increased risk for vitamin D deficiency. We will recruit 150 healthy children, 6 to 36 months of age, with risk factors for vitamin D deficiency (premature birth, breast feeding, dairy product avoidance, etc.). Based on previous studies in the US, we anticipate about 12% of these subjects will have vitamin D deficiency. Subjects will have a physical exam targeted to signs of rickets. Laboratories will include a random urine sample for calcium-to-creatinine ratio and blood for calcium, creatinine, alkaline phosphatase, phosphorus, magnesium, intact PTH, and 25-hydroxy vitamin D. Subjects with biochemical evidence of rickets will have x-rays done of the left wrist and knees that will be scored according to previously published rickets scores.

Potential Impact. Vitamin D deficiency is increasingly recognized as a common source of morbidity in both developed and undeveloped countries. The validation of a noninvasive and inexpensive screening tool for vitamin D deficiency would allow for large scale screening of at risk populations and detect this problem early, preventing the morbidities of rickets.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vitamin D Deficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* In one of the 6 high-risk groups between the age of 6 months and 3 years.

Exclusion Criteria

* known familial rickets (hypophosphatemic or vitamin D resistant)
* known parathyroid hormone problems
* any child on diuretics
* presence of a chronic disease or use of medications known to affect vitamin D metabolism
* renal insufficiency
* known malabsorption
* rickets secondary to other syndromes (e.g. Fanconi syndrome)

Minimum Eligible Age

6 Months

Maximum Eligible Age

3 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes